Skip to main content
. 2021 Mar 5;13(3):854. doi: 10.3390/nu13030854

Table 2.

Complete Blood Count.

Pre d (95% CI) Day 45 d (95% CI) Day 90 d (95% CI) p-Value
WBC (K/uL)
BHB 6.62 ± 1.74 0.62(−2.81, 0.60) 6.33 ± 1.14 0.62(−2.75, 0.66) 6.48 ± 1.22 0.04 (−1.65, 1.76) 0.0999
PLA 7.72 ± 1.81 7.38 ± 2.11 6.43 ± 1.61
RBC (M/uL)
BHB 4.75 ± 0.23 0.06(−0.30, 0.33) 4.79 ± 0.28 0.25(−0.24, 0.40) 4.71 ± 0.19 0.39(−0.42, 0.21) 0.0620
PLA 4.73 ± 0.43 4.71 ± 0.35 4.81 ± 0.31
Hemoglobin (g/dL)
BHB 14.12 ± 0.49 1.04(0.03, 1.54) 14.20 ± 0.49 1.32(0.24, 1.75) 13.98 ± 0.55 0.88(−0.16, 1.35) 0.1194
PLA 13.33 ± 0.96 13.21 ± 0.94 13.38 ± 0.79
Hematocrit (%)
BHB 41.58 ± 1.23 0.41(−1.21, 2.98) 41.88 ± 1.69 0.66(−0.74, 3.45) 40.63 ± 1.91 0.45(−1.27, 2.92) 0.7144
PLA 40.70 ± 2.77 40.52 ± 2.37 39.8 ± 1.81
MCV (fl)
BHB 87.83 ± 2.66 0.32(−3.58, 6.64) 87.50 ± 3.92 0.18(−4.21, 6.01) 86.33 ± 4.09 0.64(−1.88, 8.34) 0.0830
PLA 86.30 ± 6.11 86.60 ± 6.08 83.10 ± 5.86
MCH (pg)
BHB 29.80 ± 1.72 0.62(−0.87, 3.77) 29.71 ± 1.36 0.65(−0.81, 3.83) 29.71 ± 1.30 0.94(−0.52, 4.12) 0.6868
PLA 28.35 ± 3.11 28.20 ± 3.00 27.91 ± 2.39
MCHC (g/dL)
BHB 33.98 ± 1.19 0.86(0.05, 2.34) 33.93 ± 0.54 1.30(0.19, 2.48) 34.41 ± 0.75 0.94(−0.36, 1.94) 0.5386
PLA 32.78 ± 1.58 32.60 ± 1.34 33.62 ± 0.92
RDW (%)
BHB 12.15 ± 0.55 0.97(−1.89, 0.19) 12.20 ± 0.45 0.78(−1.79, 0.29) 12.12 ± 0.49 0.65(−1.83, 0.26) 0.9048
PLA 13.00 ± 1.11 12.95 ± 1.29 12.90 ± 1.64
Platelets (k/uL)
BHB 305.58 ± 53.63 0.10(−68.45, 54.62) 282.42 ± 42.79 0.40(−81.02, 42.05) 293.83 ± 51.58 0.17(−70.80, 52.27) 0.5519
PLA 312.50 ± 81.45 302.9 ± 59.23 303.10 ± 59.59

Data reported in mean and standard deviation. p-value is from group by time interaction effect. WBC: White blood Cell, RBC: Red Blood Cell, MCV: Mean Cell Volume, MCH: Mean Cell Hemoglobin, MCHC: Mean Cell Hemoglobin Concentration, RDW: Red Cell Distribution Width. 95% CI = 95% confidence interval of the mean difference between groups. d = Cohen’s d between-group effect size [(BHB-PLA)/SDpooled].